Chronic kidney disease (CKD) affects 13% of the US population. 1 Although a significant
proportion of these patients progress to end-stage renal disease (ESRD) requiring renal …

Background Management of coronary artery disease in patients undergoing transcatheter
aortic valve implantation is uncertain. Fractional flow reserve (FFR) has never been clinically …

Aims To compare clinical outcome in Chronic kidney disease (CKD) patients receiving
coronary stents according to stent type BMS versus DES and 1st generation versus 2nd …

Objectives The purpose of this study was to evaluate the clinical impact of chronic kidney
disease (CKD) on clinical outcomes in contemporary practice of percutaneous coronary …

Background: In patients undergoing percutaneous coronary intervention (PCI), drug-eluting
stents (DES) reduce repeat revascularizations compared with bare-metal stents (BMS), but …

Objectives To compare the long-term outcomes of coronary artery bypass grafting (CABG)
vs. percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) for coronary …

Patients with advanced chronic kidney disease have an enormous burden of cardiovascular
morbidity and mortality, but, paradoxically, their representation in randomized trials for the …

Patients with end-stage renal disease (ESRD) undergoing evaluation for kidney and/or
pancreas transplantation represent a population with unique cardiovascular (CV) profiles …

Background Drug‐eluting stents (DES s) and bare metal stents (BMS s) are both
recommended to improve coronary revascularization and to treat coronary artery disease in …

Background Loss to follow‐up (LTFU) is common in randomized controlled trials. However,
its potential impact on primary outcomes from cardiovascular randomized controlled trials is …